HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 43 filers reported holding HARPOON THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $46,000 | -38.7% | 9,287 | -6.6% | 0.00% | – |
| Q4 2021 | $75,000 | -7.4% | 9,940 | -2.9% | 0.00% | – |
| Q3 2021 | $81,000 | -44.1% | 10,238 | -2.3% | 0.00% | – |
| Q2 2021 | $145,000 | -12.1% | 10,481 | +32.7% | 0.00% | -100.0% |
| Q1 2021 | $165,000 | +58.7% | 7,896 | +26.5% | 0.00% | – |
| Q4 2020 | $104,000 | -2.8% | 6,241 | -1.3% | 0.00% | -100.0% |
| Q3 2020 | $107,000 | 0.0% | 6,323 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $107,000 | +114.0% | 6,467 | +49.0% | 0.00% | – |
| Q1 2020 | $50,000 | -26.5% | 4,341 | -5.5% | 0.00% | – |
| Q4 2019 | $68,000 | +7.9% | 4,593 | +0.3% | 0.00% | – |
| Q3 2019 | $63,000 | +28.6% | 4,580 | +21.5% | 0.00% | – |
| Q2 2019 | $49,000 | +226.7% | 3,771 | +130.5% | 0.00% | – |
| Q1 2019 | $15,000 | – | 1,636 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,524,425 | $66,916,000 | 29.45% |
| MPM BioImpact LLC | 3,898,422 | $57,658,000 | 20.43% |
| New Leaf Venture Partners, L.L.C. | 2,921,405 | $43,208,000 | 9.39% |
| Soleus Capital Management, L.P. | 123,200 | $1,822,000 | 1.76% |
| EcoR1 Capital, LLC | 908,547 | $13,437,000 | 1.21% |
| Orbimed Advisors | 2,446,409 | $36,182,000 | 0.52% |
| Artal Group S.A. | 850,000 | $12,572,000 | 0.49% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,031 | $5,680,000 | 0.47% |
| Cormorant Asset Management, LP | 649,994 | $9,613,000 | 0.38% |
| Fosun International Ltd | 190,483 | $2,817,000 | 0.23% |